← FDA Drug Approvals (Drugs@FDA)

METHYLPREDNISOLONE SODIUM SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABRAXIS PHARM · Approved 1986-03-28

Drug application

FDA Application #

ANDA089144

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLPREDNISOLONE SODIUM SUCCINATE

Generic name

Methylprednisolone Sodium Succinate

Active ingredients

METHYLPREDNISOLONE SODIUM SUCCINATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ABRAXIS PHARM

First approval

1986-03-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown